Kyruus Recruits Jamie Kiggen as its New Chief Financial Officer

BOSTON, MA, UNITED STATES - Aug 6, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Jamie Kiggen has joined its executive leadership team as Chief Financial Officer

Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite

CONNECTICUT, CT, UNITED STATES - Aug 6, 2020 - Phesi, a data-driven provider of clinical development analytics products and solutions, today announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and management

Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support

KING OF PRUSSIA, PA - Aug 6, 2020 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials

Raremark® launches the Xperiome™ patient-powered knowledge platform to deliver new therapies faster and smarter

LONDON, UK - Aug 6, 2020 - Raremark®, the leading online patient community in rare disease, has today launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new therapies faster and smarter

Panthera’s UK oncology clinical trial sites open for studies

PRESTON, UNITED KINGDOM - Aug 3, 2020 -  

• More than 1000 International Cancer Trials Suspended Due to COVID-19 

• Panthera working with the state of the art  Rutherford Cancer Centres across the UK  is open for clinical research activities including screening

Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin

CRAMLINGTON, UNITED KINGDOM - Jul 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has signed an agreement with Moleculin Biotech, Inc

Abzena appoints Matthew LeClair as SVP and Site Head of San Diego Operations

SAN DIEGO, CA, UNITED KINGDOM - Aug 3, 2020 - Cambridge, UK and San Diego, CA, 3 August 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego Operations

SkinCheck affordable skin cancer screening re-opens

CAMBRIDGE, UK - Aug 3, 2020 - Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, is reopening its SkinHealth SkinCheck clinics following enforced closure due to COVID-19

LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy

AMSTERDAM, THE NETHERLANDS - Aug 3, 2020 - LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development

Creative Peptides Provides Synthetic Peptides for Developing Vaccines

SHIRLEY, NY - Aug 3, 2020 - In the current COVID-19 pandemic, synthetic peptides play an important role in vaccine development. Creative Peptides, a supplier mainly engaged in the production of biologically active peptides, recently announced that it can provide synthetic peptides for vaccine development

Alfa Chemistry Materials—a New Option of Material Building Blocks

NY, NY - Aug 1, 2020 - Material building blocks are of vital importance in various areas such as in the production of semiconductors

Mitrefinch adds Facial Recognition to its Time and Attendance Solutions

NEWTON, MA - Jul 30, 2020 - Mitrefinch delivers biometric and cloud based  time and attendance solutions for midsize and large organizations including hospitals, medical facilities and senior care centers across North and South America

Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies

HOPKINTON, MA, UNITED STATES - Jul 29, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, and F-star Therapeutics, Limited (“F-star”), a privately-held clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announced that the companies have entered into a definitive share exchange agreement pursuant to which Spring Bank will, subject to stockholder approval, acquire all of the outstanding share capital of F-star in exchange for newly issued shares of Spring Bank in an all-stock transaction

Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer

IRVINE, CA - Jul 29, 2020 - Irvine, California, July 29, 2020 – Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the appointment of Brian Dow as Chief Financial Officer in the continued buildout of the Company’s leadership team

CareCom Joins Lyniate’s Co-Creation Lab to Address Interoperability

BOSTON, MA, UNITED STATES - Jul 29, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced a partnership with CareCom, a leading provider of terminology services management, to drive interoperability innovation

Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners

CAMBRIDGE, UNITED KINGDOM - Jul 28, 2020 - Cambridge, UK, Bristol, PA and San Diego, CA -28 July 2020 - Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd

HETHEL, NORFOLK, UNITED KINGDOM - Jul 28, 2020 - Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd (SB3000 Ltd), a pioneer in green, continuous manufacturing of pharmaceutical products

Agendia Publishes Unprecedented Full Genome Dataset from MINDACT Trial for the Advancement of Translational Research in Communications Biology

NEW YORK, NY, UNITED STATES - Jul 27, 2020 - Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the publication of MINDACT trial data in the July 27 issue of Communications Biology, a Nature Publishers Journal

Phosplatin Therapeutics Receives Notice of US Patent Issuance for PT-112 as Therapeutic Agent for Treatment of Bone or Blood Cancers

NEW YORK, NY - Jul 23, 2020 - Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No

Alfa Chemistry Optimized Precious Metal Catalysts Recovery and Refining Service

NY, NY - Jul 23, 2020 - The New York-based chemical supplier Alfa Chemistry announced earlier this month that it has taken measures to optimize metal catalysts recovery and refining service